Ohio State University Comprehensive Cancer Center

At the 66th ASH Annual Meeting, Jason Wang, MD, discussed a significant decrease in CRS and ICANS severity with axi-cel therapy in R/R LBCL patients, attributed to bridging therapy and preemptive steroid use. This trend improves patient outcomes and reduces healthcare costs, though long-term QOL and OS data are still limited.

Nearly half of U.S. counties have at least one 'pharmacy desert' with no retail pharmacy within 10 miles, affecting vulnerable populations. Counties with more pharmacy deserts have more vulnerable residents and fewer primary care doctors, leading to difficulties in accessing prescription medication and health care services.